CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 40 filers reported holding CTI BIOPHARMA CORP in Q3 2020. The put-call ratio across all filers is 0.21 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,692,151 | -69.6% | 402,893 | -56.5% | 0.00% | -50.0% |
Q4 2022 | $5,567,117 | +562.8% | 926,309 | +542.1% | 0.00% | – |
Q3 2022 | $840,000 | -49.3% | 144,256 | -48.0% | 0.00% | -100.0% |
Q2 2022 | $1,656,000 | +2023.1% | 277,500 | +1558.3% | 0.00% | – |
Q1 2022 | $78,000 | +680.0% | 16,734 | +316.6% | 0.00% | – |
Q4 2021 | $10,000 | -23.1% | 4,017 | -6.1% | 0.00% | – |
Q3 2021 | $13,000 | -23.5% | 4,278 | -36.6% | 0.00% | – |
Q2 2021 | $17,000 | -41.4% | 6,747 | -32.3% | 0.00% | – |
Q1 2021 | $29,000 | +107.1% | 9,971 | +133.1% | 0.00% | – |
Q4 2020 | $14,000 | +40.0% | 4,278 | -12.0% | 0.00% | – |
Q3 2020 | $10,000 | -66.7% | 4,862 | -81.2% | 0.00% | – |
Q2 2020 | $30,000 | +87.5% | 25,862 | +46.4% | 0.00% | – |
Q1 2020 | $16,000 | +6.7% | 17,667 | +87.9% | 0.00% | – |
Q4 2019 | $15,000 | +400.0% | 9,404 | +130.7% | 0.00% | – |
Q3 2019 | $3,000 | -57.1% | 4,076 | -50.2% | 0.00% | – |
Q2 2019 | $7,000 | +16.7% | 8,185 | +38.0% | 0.00% | – |
Q1 2019 | $6,000 | -75.0% | 5,930 | -81.7% | 0.00% | – |
Q4 2018 | $24,000 | -57.1% | 32,381 | +25.5% | 0.00% | – |
Q3 2018 | $56,000 | -44.6% | 25,805 | +26.5% | 0.00% | – |
Q2 2018 | $101,000 | +71.2% | 20,407 | +34.7% | 0.00% | – |
Q1 2018 | $59,000 | +96.7% | 15,155 | +35.6% | 0.00% | – |
Q4 2017 | $30,000 | +30.4% | 11,176 | +55.2% | 0.00% | – |
Q3 2017 | $23,000 | +64.3% | 7,203 | +66.0% | 0.00% | – |
Q2 2017 | $14,000 | -30.0% | 4,338 | -9.9% | 0.00% | – |
Q1 2017 | $20,000 | – | 4,817 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|